Prolonged prothrombin time (PT) and minimally affected activated partial thromboplastin time (aPTT) in COVID-19 suggest a predominant tissue factor-factor VIIa (TF-F VIIa)-mediated activation of the extrinsic coagulation pathway. The gene discussed is F2; the disease is COVID-19.